| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 250.272 | 505.486 | 764.959 | 706.946 | 1.380.015 | 1.682.137 |
| Total Income - EUR | - | - | - | - | 250.465 | 513.567 | 765.350 | 707.896 | 1.380.538 | 1.686.207 |
| Total Expenses - EUR | - | - | - | - | 189.708 | 336.500 | 646.782 | 652.543 | 1.020.757 | 1.450.866 |
| Gross Profit/Loss - EUR | - | - | - | - | 60.757 | 177.067 | 118.568 | 55.353 | 359.781 | 235.340 |
| Net Profit/Loss - EUR | - | - | - | - | 58.759 | 172.286 | 111.326 | 49.110 | 314.572 | 202.350 |
| Employees | - | - | - | - | 2 | 2 | 3 | 4 | 4 | 6 |
Check the financial reports for the company - Gisco Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.831 | 3.639 | 22.657 | 19.109 | 45.256 | 62.518 |
| Current Assets | - | - | - | - | 115.583 | 248.239 | 287.490 | 453.712 | 942.663 | 774.435 |
| Inventories | - | - | - | - | 27.644 | 94.192 | 120.929 | 327.207 | 292.911 | 362.079 |
| Receivables | - | - | - | - | 54.242 | 104.399 | 104.186 | 114.381 | 600.045 | 141.093 |
| Cash | - | - | - | - | 33.697 | 49.649 | 62.375 | 12.125 | 49.707 | 271.263 |
| Shareholders Funds | - | - | - | - | 58.802 | 172.328 | 111.366 | 49.158 | 363.582 | 202.399 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 58.612 | 79.551 | 200.803 | 426.403 | 627.202 | 635.380 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.318 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Gisco Med S.r.l.